Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 19 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Izraēla - angļu - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

fresenius kabi, usa, llc - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - cardioplegic solution when suitably buffered in combination with ischemia and hypothermia is used to induce cardiac arrest during open heart surgery. cardioplegic solution must not be administered without the addition of 8.4% sodium bicarbonate injection, usp. not for intravenous injection. this solution is only for instillation into cardiac vasculature after buffering with sodium bicarbonate. flexible plastic container (free flex ® bag) do not remove solution container from its overwrap until immediately before use. the intact port cap provides visual tamper evidence. do not use if port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. remove the solution container from the overwrap. - check the solution container for leaks by squeezing firmly. if leaks are found, discard. to add 10 ml of 8.4% sodium bicarbonate injection, usp, and i

Armēnija - angļu - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo operations uk ltd. - eptifibatide - solution for injection - 2mg/ml

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20, sodium cation - unii:lyr4m0nh37) - neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion. not for use as a systemic alkalizer. none known.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

hormosan pharma gmbh - eletriptan - film-coated tablet - 20 milligram(s) - eletriptan

Īrija - angļu - HPRA (Health Products Regulatory Authority)

hormosan pharma gmbh - eletriptan - film-coated tablet - 40 milligram(s) - eletriptan